Literature DB >> 7564116

Plasma protein adsorption to highly permeable hemodialysis membranes.

W R Clark1, W L Macias, B A Molitoris, N H Wang.   

Abstract

Although membrane adsorption of plasma proteins is one of several factors determining the biocompatibility and mass transfer characteristics of a hemodialyzer, this process has not been evaluated rigorously. We performed an equilibrium and kinetic analysis of the binding of proteins of differing molecular weight to highly permeable membranes of differing hydrophobicity and surface change. Hydrophobic, anionic polyacrylonitrile (PAN) and hydrophilic, uncharged cellulose triacetate (CT) membrane fragments were incubated in buffer containing radioiodinated beta 2-microglobulin (beta 2m) or bovine serum albumin (BSA). From an initial solution concentration of 50 mg/liter, both membranes adsorbed significantly more beta 2m than BSA at equilibrium (PAN, 352 +/- 30 vs. 32.1 +/- 2.4 ng; CT, 87.0 +/- 0.6 vs. 30.8 +/- 1.7 ng). These results were consistent with membrane pore exclusion of BSA. Comparison of the slopes of the equilibrium isotherm lines (concentration range, 0 to 220 mg/liter) showed the PAN binding affinity for beta 2m and BSA was 28 and 1.4 times that of CT, respectively. In kinetic studies, the approach to equilibrium versus (time)1/2 was assessed. For all protein-membrane combinations, this relationship was linear, consistent with a diffusion-controlled process. This latter characteristic permitted the determination of beta 2m membrane diffusivity values for both PAN and CT, which were found to be 0.30 and 3.25 x 10(-7) cm2/sec, respectively. These data suggest membrane hydrophobicity more significantly influences the binding of low-molecular weight proteins than that of pore-excluded proteins. In addition, these results demonstrate electrostatic membrane-protein interactions may influence the kinetics of both the adsorption and transmembrane mass transfer of plasma proteins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7564116     DOI: 10.1038/ki.1995.317

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  11 in total

Review 1.  Enhancing dialyser clearance-from target to development.

Authors:  Kamonwan Tangvoraphonkchai; Andrew Davenport
Journal:  Pediatr Nephrol       Date:  2017-04-12       Impact factor: 3.714

2.  Amino Acid Loss during Continuous Venovenous Hemofiltration in Critically Ill Patients.

Authors:  Sandra N Stapel; Ruben J de Boer; Patrick J Thoral; Marc G Vervloet; Armand R J Girbes; Heleen M Oudemans-van Straaten
Journal:  Blood Purif       Date:  2019-07-10       Impact factor: 2.614

3.  Longitudinal hemodiafilter performance in modeled continuous renal replacement therapy.

Authors:  Deborah A Pasko; Mariann D Churchwell; Noha N Salama; Bruce A Mueller
Journal:  Blood Purif       Date:  2011-03-02       Impact factor: 2.614

4.  Proteomic investigations on the effect of different membrane materials on blood protein adsorption during haemodialysis.

Authors:  Andrea Urbani; Vittorio Sirolli; Santina Lupisella; Stefano Levi-Mortera; Barbara Pavone; Luisa Pieroni; Luigi Amoroso; Roberto Di Vito; Sonia Bucci; Sergio Bernardini; Paolo Sacchetta; Mario Bonomini
Journal:  Blood Transfus       Date:  2012-05       Impact factor: 3.443

Review 5.  Isolated ultrafiltration in heart failure patients.

Authors:  Maria Rosa Costanzo; Claudio Ronco
Journal:  Curr Cardiol Rep       Date:  2012-06       Impact factor: 2.931

Review 6.  Ultrafiltration in critically ill patients treated with kidney replacement therapy.

Authors:  Raghavan Murugan; Rinaldo Bellomo; Paul M Palevsky; John A Kellum
Journal:  Nat Rev Nephrol       Date:  2020-11-11       Impact factor: 28.314

7.  Ex vivo Rezafungin Adsorption and Clearance During Continuous Renal Replacement Therapy.

Authors:  Soo Min Jang; Grayson Hough; Bruce A Mueller
Journal:  Blood Purif       Date:  2018-06-14       Impact factor: 2.614

8.  Etanercept clearance during an in vitro model of continuous venovenous hemofiltration.

Authors:  Geoffrey M Fleming; Noha N Salama; Saada K Eid; Kenneth R Cooke; Bruce A Mueller
Journal:  Blood Purif       Date:  2009-09-01       Impact factor: 2.614

Review 9.  Blood-incompatibility in haemodialysis: alleviating inflammation and effects of coagulation.

Authors:  Sudhir K Bowry; Fatih Kircelli; Rainer Himmele; Sagar U Nigwekar
Journal:  Clin Kidney J       Date:  2021-12-27

10.  Clinical Validation of Therapeutic Drug Monitoring of Imipenem in Spent Effluent in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Pilot Study.

Authors:  Aiping Wen; Zhe Li; Junxian Yu; Ren Li; Sheng Cheng; Meili Duan; Jing Bai
Journal:  PLoS One       Date:  2016-04-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.